Article Details

AstraZeneca's Enhertu demonstrates 'statistically significant' survival rates in ... - Sharecast.com

Retrieved on: 2022-02-21 07:18:55

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca's Enhertu demonstrates 'statistically significant' survival rates in ... - Sharecast.com. View article details on hiswai:

Excerpt

Drugmaker AstraZeneca said on Monday that high-level results from a pivotal DESTINY-Breast04 Phase III trial showed that its Enhertu drug ...

Article found on: www.sharecast.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up